<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>25(3)</volume><submitter>Wu RR</submitter><pubmed_abstract>&lt;b>Aim:&lt;/b> Understanding barriers and facilitators to pharmacogenomics (PGx) implementation and how to structure a clinical program with the Veterans Health Administration (VA). &lt;b>Materials &amp; methods:&lt;/b> Healthcare provider (HCP) survey at 20 VA facilities assessing PGx knowledge/acceptance and qualitative interviews to understand how best to design and sustain a national program. &lt;b>Results:&lt;/b> 186 (12% response rate) surveyed believed PGx informs drug efficacy (74.7%) and adverse events (71.0%). Low confidence in knowledge (43.0%) and ability to implement (35.4-43.5%). 23 (60.5% response rate) interviewees supported a nationally program to oversee VA education, consultation and IT resources. Prescribing HCPs should be directing local activities. &lt;b>Conclusion:&lt;/b> HCPs recognize PGx value but are not prepared to implement. Healthcare systems should build system-wide programs for implementation education and support.</pubmed_abstract><journal>Pharmacogenomics</journal><pagination>133-145</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10964838</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration.</pubmed_title><pmcid>PMC10964838</pmcid><pubmed_authors>Sperber NR</pubmed_authors><pubmed_authors>Burrell TA</pubmed_authors><pubmed_authors>Benevent R</pubmed_authors><pubmed_authors>Bates JS</pubmed_authors><pubmed_authors>Voora D</pubmed_authors><pubmed_authors>Villa D</pubmed_authors><pubmed_authors>Weeraratne D</pubmed_authors><pubmed_authors>Wu RR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration.</name><description>&lt;b>Aim:&lt;/b> Understanding barriers and facilitators to pharmacogenomics (PGx) implementation and how to structure a clinical program with the Veterans Health Administration (VA). &lt;b>Materials &amp; methods:&lt;/b> Healthcare provider (HCP) survey at 20 VA facilities assessing PGx knowledge/acceptance and qualitative interviews to understand how best to design and sustain a national program. &lt;b>Results:&lt;/b> 186 (12% response rate) surveyed believed PGx informs drug efficacy (74.7%) and adverse events (71.0%). Low confidence in knowledge (43.0%) and ability to implement (35.4-43.5%). 23 (60.5% response rate) interviewees supported a nationally program to oversee VA education, consultation and IT resources. Prescribing HCPs should be directing local activities. &lt;b>Conclusion:&lt;/b> HCPs recognize PGx value but are not prepared to implement. Healthcare systems should build system-wide programs for implementation education and support.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2025-04-21T23:48:44.431Z</modification><creation>2025-04-05T19:19:53.873Z</creation></dates><accession>S-EPMC10964838</accession><cross_references><pubmed>38440834</pubmed><doi>10.2217/pgs-2023-0193</doi></cross_references></HashMap>